-
Estimation of HER2-Negative Metastatic Breast Cancer Population Eligible for Innovative Treatments in France
Sep 9, 2025, 16:22 PM -
Transparency Tested: Conflict of Interest in EU HTA
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Oteseconazole vs. Fluconazole for Patients With Severe Vulvovaginal Candidiasis in China
Sep 9, 2025, 16:22 PM -
Evaluating the Impact of Implementing AI-Assisted Contouring on Radiotherapy Staff and Workflows
Sep 9, 2025, 16:22 PM -
Gender Differences in the Economic Burden of Alcohol Use in Belgium
Sep 9, 2025, 16:22 PM -
An Update on the Evolving Use of Artificial intelligence and Machine Learning (AI/ML) in Systematic Literature Reviews (SLRs)
Sep 9, 2025, 16:22 PM -
Children With Asthma Receiving Dupilumab Plus Medium-Dose Inhaled Corticosteroids Had Improved Exacerbations, Lung Function, and Airway Inflammation Compared To Those Receiving Placebo Plus High-Dose Inhaled Corticosteroids
Sep 9, 2025, 16:22 PM -
Advanced Therapies and the Unmet Need in Systemic Lupus Erythematosus Patients: Results From a Real-World Study in the United States and Germany
Sep 9, 2025, 16:22 PM -
Comorbidities and Comedication Among Individuals in Treatment for ADHD: A Danish Nationwide Study
Sep 9, 2025, 16:22 PM -
Markov Model-Based Cost-Effectiveness Evaluation of ROSA® vs. Manual Total Knee Arthroplasty: Sweden Payer Perspective
Sep 9, 2025, 16:22 PM -
Fit-for-Purpose Real-World Data: Lessons From FDA QCARD and EMA Data Quality Framework
Sep 9, 2025, 16:22 PM -
A Health Economic Evaluation Framework for Implementing a Digital Survivorship Passport for Childhood Cancer Survivors
Sep 9, 2025, 16:22 PM -
Disability Resource Utilization and Caregiver Support Among a Real-World Sample of Patients With Transthyretin Amyloidosis With Polyneuropathy
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis Of The 13-Valent And 20-Valent Pneumococcal Conjugate Vaccine In The Kazakh Adult Population
Sep 9, 2025, 16:22 PM -
Survival Outcomes in People Living With HIV Who Experienced Progressive Multifocal Leukoencephalopathy Compared to the General Population
Sep 9, 2025, 16:22 PM -
Understanding Drivers on Healthcare Resource Utilization Costs Among People Living With Obesity in UK Clinical Practice
Sep 9, 2025, 16:22 PM -
Characterizing the UK Population Living With Von Willebrand Disease: Foundational Data for Health Economics and Outcomes Research
Sep 9, 2025, 16:22 PM -
The Public Health and Economic Effects of Various RSV Vaccination Strategies With RSVpreF Among Adults in France
Sep 9, 2025, 16:22 PM -
Treatment With Semaglutide Reduces the Complication Costs Among Type 2 Diabetes Patients With CKD in China: A Short-Term Cost Analysis Based on the FLOW Trial
Sep 9, 2025, 16:22 PM -
Cost Effectiveness and Budget Impact Analysis of Benralizumab for Treating Severe Uncontrolled Eosinophilic Asthma in Egypt
Sep 9, 2025, 16:22 PM
